1 Navidea Biopharmaceuticals Inc Receivables Turnover Ratio (NAVB), from the third quarter 2023 to the third quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Navidea Biopharmaceuticals Inc   (NAVB)
 

Navidea Biopharmaceuticals Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


According to Navidea Biopharmaceuticals Inc Balance Sheet, in the third quarter 2023, company has not reported any Accounts receivable.
See Navidea Biopharmaceuticals Inc Balance Sheet

If we take a look into Healthcare sector Navidea Biopharmaceuticals Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Navidea Biopharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NAVB Receivables Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change - - - -98.79 % -92.2 %
Receivable Turnover Ratio (TTM) - - - - -
NAVB's Total Ranking # # # # #
Accounts Receivable average collection period days - - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change - - - -91.88 % -86.93 %


Receivable Turnover Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





NAVB Company Profile • Back to NAVB Efficiency Comparisons • Compare NAVB Receivables Turnover Ratio to its Competitors

Financial Statements
Navidea Biopharmaceuticals Inc 's Accounts Receivable $ 0 Millions Visit NAVB's Balance sheet
Navidea Biopharmaceuticals Inc 's Sales TTM $ 0 Millions Visit NAVB's Income Statement
Sources of NAVB's Revenues Visit NAVB's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NAVB's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NAVB's Growth Rates NAVB's Roa NAVB's Inventory Turnover Ratio NAVB's Dividend Comparisons
NAVB's Profitability Ratios NAVB's Roi NAVB's Asset Turnover Ratio NAVB's Dividend Growth
NAVB's Valuation Ratios NAVB's Roe NAVB's Financial Strength Ratios NAVB's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023

Date modified: 2026-08-29T17:28:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.